Literature DB >> 25700586

Evaluation and management of the elderly patient presenting with cognitive complaints.

Kerry L Hildreth1, Skotti Church2.   

Abstract

Cognitive complaints are common in the geriatric population. Older adults should routinely be asked about any concerns about their memory or thinking, and any cognitive complaint from the patient or an informant should be evaluated rather than be attributed to aging. Several screening instruments are available to document objective impairments and guide further evaluation. Management goals for patients with cognitive impairment are focused on maintaining function and independence, providing caregiver support, and advance care planning. There are currently no treatments to effectively prevent or treat dementia. Increasing appreciation of the heterogeneity of Alzheimer disease may lead to novel treatment approaches.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Cognitive impairment; Dementia; Elderly

Mesh:

Year:  2014        PMID: 25700586      PMCID: PMC4399854          DOI: 10.1016/j.mcna.2014.11.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  130 in total

1.  Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia.

Authors:  Mario F Mendez; Jill S Shapira; Aaron McMurtray; Eliot Licht
Journal:  Am J Geriatr Psychiatry       Date:  2007-01       Impact factor: 4.105

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

5.  Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling.

Authors:  Satoshi Fujita; Blake B Rasmussen; Jerson G Cadenas; Micah J Drummond; Erin L Glynn; Fred R Sattler; Elena Volpi
Journal:  Diabetes       Date:  2007-03-09       Impact factor: 9.461

6.  Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Authors:  Sudeep S Gill; Geoffrey M Anderson; Hadas D Fischer; Chaim M Bell; Ping Li; Sharon-Lise T Normand; Paula A Rochon
Journal:  Arch Intern Med       Date:  2009-05-11

7.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Authors:  Philip R Gehrman; Donald J Connor; Jennifer L Martin; Tamar Shochat; Jody Corey-Bloom; Sonia Ancoli-Israel
Journal:  Am J Geriatr Psychiatry       Date:  2009-02       Impact factor: 4.105

8.  Patients dying with dementia: experience at the end of life and impact of hospice care.

Authors:  Joseph W Shega; Gavin W Hougham; Carol B Stocking; Deon Cox-Hayley; Greg A Sachs
Journal:  J Pain Symptom Manage       Date:  2008-02-08       Impact factor: 3.612

9.  Antipsychotic drug use and mortality in older adults with dementia.

Authors:  Sudeep S Gill; Susan E Bronskill; Sharon-Lise T Normand; Geoffrey M Anderson; Kathy Sykora; Kelvin Lam; Chaim M Bell; Philip E Lee; Hadas D Fischer; Nathan Herrmann; Jerry H Gurwitz; Paula A Rochon
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

Review 10.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Birks
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
View more
  15 in total

1.  Regulatory role of microRNA-30b and plasminogen activator inhibitor-1 in the pathogenesis of cognitive impairment.

Authors:  Xiuqin Li; Yong Gao; Zhaoyun Meng; Cui Zhang; Qinde Qi
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

2.  Dementia: What pharmacists need to know.

Authors:  Silvia Duong; Tejal Patel; Feng Chang
Journal:  Can Pharm J (Ott)       Date:  2017-02-07

3.  The Oldest Old in the Emergency Department: Impact of Renal Function.

Authors:  T Brünnler; M Drey; G Dirrigl; C Weingart; F Rockmann; C Sieber; U Hoffmann
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

4.  Memory complaints, dementia, and neuropathology in older blacks and whites.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Debra A Fleischman; Julie A Schneider; Kumar B Rajan; Jeremy J Pruzin; Raj C Shah; Denis A Evans; Lisa L Barnes; David A Bennett
Journal:  Ann Neurol       Date:  2018-03-30       Impact factor: 10.422

5.  Association between dementia and hepatitis B and C virus infection.

Authors:  Hyo Geun Choi; Jae Seung Soh; Jae Sung Lim; Song Yong Sim; Suk Woo Lee
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

6.  Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.

Authors:  Carlos Calderón; Christian Beyle; Oscar Véliz-García; Juan Bekios-Calfa
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

Review 7.  Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature.

Authors:  Daejin Lim; Jae-Ho Jeong; Juhyun Song
Journal:  CNS Neurosci Ther       Date:  2021-05-04       Impact factor: 5.243

Review 8.  Aging in two languages: Implications for public health.

Authors:  Ellen Bialystok; Jubin Abutalebi; Thomas H Bak; Deborah M Burke; Judith F Kroll
Journal:  Ageing Res Rev       Date:  2016-03-16       Impact factor: 10.895

Review 9.  Current Development in Elderly Comprehensive Assessment and Research Methods.

Authors:  Shantong Jiang; Pingping Li
Journal:  Biomed Res Int       Date:  2016-03-03       Impact factor: 3.411

10.  Group Intensive Cognitive Activation in Patients with Major or Mild Neurocognitive Disorder.

Authors:  Simonetta Panerai; Domenica Tasca; Sabrina Musso; Valentina Catania; Federica Ruggeri; Alberto Raggi; Stefano Muratore; Giuseppina Prestianni; Cinzia Bonforte; Raffaele Ferri
Journal:  Front Behav Neurosci       Date:  2016-02-29       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.